About Cradle
Cradle is a company based in Delft (Netherlands) founded in 2021 by Stef Van Grieken and Jelle Prins. It operates as a SaaS (Software-as-a-Service) and Subscription Services. Cradle has raised $102.71 million across 3 funding rounds from investors including IVP, Index Ventures and Kindred. Cradle offers products and services including Cradle AI Platform. Cradle operates in a competitive market with competitors including Nimbus Therapeutics, EvolutionaryScale, Evozyne, Profluent Bio and Frontier Medicines, among others.
- Headquarter Delft, Netherlands
- Founders Stef Van Grieken, Jelle Prins
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$102.71 M (USD)
in 3 rounds
-
Latest Funding Round
$73 M (USD), Series B
Nov 26, 2024
-
Investors
IVP
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cradle
Cradle offers a comprehensive portfolio of products and services, including Cradle AI Platform.
AI platform used to optimize protein design efficiently.
People of Cradle
Unlock access to complete
Funding Insights of Cradle
Cradle has successfully raised a total of $102.71M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $73 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cradle
Cradle has secured backing from 7 investors, including venture fund and angel investors. Prominent investors backing the company include IVP, Index Ventures and Kindred.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth in technology companies is supported through venture capital.
|
Locked | Locked | Locked | |
|
Venture capital investments in technology startups and entrepreneurs.
|
Locked | Locked | Locked | |
|
Venture capital funding is offered to pre-seed and seed startups.
|
Locked | Locked | Locked |
Investor details for Cradle
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cradle
Investment portfolio details for Cradle
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cradle
Detailed financials for Cradle
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cradle Comparisons
Peer comparison for Cradle
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cradle
Cradle operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nimbus Therapeutics, EvolutionaryScale, Evozyne, Profluent Bio and Frontier Medicines, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
Provider of an AI models for protein design
|
|
| Locked | Locked | Locked |
Developer of proteins using protein engineering technology
|
|
| Locked | Locked | Locked |
An AI-based protein design platform is provided for drug discovery.
|
|
| Locked | Locked | Locked |
Bioinformatics platform is developed for drug discovery and chemoproteomics.
|
Detailed competitors of Cradle
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cradle
Complete news archive for Cradle
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cradle
Cradle was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Cradle is headquartered in Delft, Netherlands. It is registered at Delft, South Holland, Netherlands.
Stef Van Grieken is the current CEO of Cradle. They have also founded this company.
Cradle is a funded company, having raised a total of $102.71M across 3 funding rounds to date.
Cradle is engaged in developing AI-based software for protein engineering. Solutions are provided to biopharma and industrial bio sectors. The platform is designed to generate and optimize protein candidates, reducing experimental timelines. Applications are supported across therapeutics, agricultural solutions, and food ingredients. Data privacy and security are prioritized with bank-grade protection. Models are continuously improved through proprietary lab testing in Amsterdam.
Cradle's top competitors include Nimbus Therapeutics, Profluent Bio and Eikon.
Cradle offers Cradle AI Platform.
Cradle has 7 investors. Key investors include IVP, Index Ventures, Kindred, Chris Gibson, and Tom Glocer.